A practical guide to the interpretation of PK/PD profiles of longer-acting analogue insulins. Part two: Insulin degludec vs. insulin glargine U300
Glucose clamp studies form an integral part of the early development of insulin therapies. Data generated in these studies are used to establish pharmacokinetic (PK) and pharmacodynamic (PD) profiles of the agents, but methodological differences confound comparison of results from different glucose...
Main Authors: | Oppel B.W. Greeff, Jacob John van Tonder, Kershlin Naidu, Alicia McMaster, Alet van Tonder, Rashem Mothilal |
---|---|
Format: | Article |
Language: | English |
Published: |
AOSIS
2018-08-01
|
Series: | South African Family Practice |
Subjects: | |
Online Access: | https://safpj.co.za/index.php/safpj/article/view/4903 |
Similar Items
-
A practical guide to the interpretation of PK/PD profiles of longer-acting analogue insulins. Part one: The principles of glucose clamp studies
by: Oppel B.W. Greeff, et al.
Published: (2018-07-01) -
Conversion from insulin glargine U-100 to insulin glargine U-300 or insulin degludec and the impact on dosage requirements
by: Scott M. Pearson, et al.
Published: (2018-04-01) -
Insulin degludec and insulin glargine 300 U/mL: Which of these two insulins causes less hypoglycemia?
by: Silvio Buscemi, et al.
Published: (2019-11-01) -
Response to insulin degludec and insulin glargine 300 U/mL: Which of these two insulins causes less hypoglycemia?
by: Mizuho Yamabe
Published: (2019-11-01) -
Day‐to‐day variability of porcine lente, insulin glargine 300 U/mL and insulin degludec in diabetic dogs
by: Michelle Miller, et al.
Published: (2021-09-01)